Clinical Trials in Pennsylvania

Showing 6261-6280 of 14,950 trials

Daily Step Count and Achieving Goal Gestational Weight Gain

NCT04605406

The purpose of this voluntary research study is to determine an optimal step count that aids in achieving the recommended weight gain during pregnancy and to use this count in future studies.

Pregnancy Related

Milton S. Hershey Medical CenterStarted Jul 2023

Hershey, Pennsylvania, United States

COMPLETEDNA36 miles

Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant

NCT03886909

The purpose of this study is to determine whether patients are able to participate in a prehabilitation program (prior to the beginning of treatment) which includes: (1) a home-based exercise program or (2) just a prehabilitation education session.

Hematopoietic Stem Cell TransplantHematologic DiseasesPhysical Activity+1 more

Milton S. Hershey Medical Center84 participantsStarted Jun 2019

Hershey, Pennsylvania, United States

COMPLETEDNA40 miles

Decreasing ED Utilization by Nudging Patients to Call Their Providers

NCT04567849

In the present study, patients will be sent a message shortly after completing a medical procedure that informs or reminds them that they can reach out to Geisinger, and how to do it, if they have any medical issues or concerns. Researchers will assess if such messages make patients more likely to contact Geisinger with post-procedure medical concerns and decrease emergency department utilization.

Emergency TreatmentTelephone Hotlines

Geisinger Clinic11,546 participantsStarted Nov 2021

Danville, Pennsylvania, United States

COMPLETEDPhase 368 miles

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

NCT03354273

This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.

Coronary Artery Disease (CAD)

GE Healthcare730 participantsStarted Jun 2018

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +50 more locations

Daily Step Count and Achieving Goal Gestational Weight Gain

Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant

Decreasing ED Utilization by Nudging Patients to Call Their Providers

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Find Trials by Condition in Pennsylvania

Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)

Simple Bone Cysts in Kids

A Trial of NT-I7 in COVID-19 (SPESELPIS)

Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions

Relapse Prevention Study in Patients With Schizophrenia

PDGeneration: Mapping the Future of Parkinson's Disease

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis

Safety and Performance of Journey II XR Total Knee System

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors